The COVID-19 world - Are we there yet?

Yoshiyuki Hamamoto
Author Information
  1. Yoshiyuki Hamamoto: Yutaka Seino Distinguished Center for Diabetes Research, Kansai Electric Power Medical Research Institute, Kobe, Japan. ORCID

Abstract

The spreading of SARS-CoV-2 virus infection is still of great concern as well as clinical and social interest. The key to conquer this pandemic would be establishment of herd immunity by vaccination and of treatment, and I have discussed issues we are facing now.

References

  1. J Diabetes Investig. 2021 Sep;12(9):1718-1722 [PMID: 33599073]
  2. Diabetes Metab Syndr. 2021 May-Jun;15(3):777-782 [PMID: 33838614]
  3. Lancet. 2021 May 01;397(10285):1637-1645 [PMID: 33933206]
  4. Diabetes Care. 2020 Dec;43(12):2999-3006 [PMID: 32994187]
  5. Nature. 2021 Apr;592(7855):616-622 [PMID: 33567448]
  6. J Diabetes Investig. 2021 Jul;12(7):1125-1127 [PMID: 34056843]
  7. Diabet Med. 2016 Aug;33(8):1094-101 [PMID: 26605507]
  8. J Diabetes Investig. 2020 Jul;11(4):792-794 [PMID: 32521120]
  9. N Engl J Med. 2021 Apr 22;384(16):1491-1502 [PMID: 33631065]
  10. N Engl J Med. 2021 Apr 15;384(15):1412-1423 [PMID: 33626250]
  11. J Diabetes Investig. 2021 Apr;12(4):479-481 [PMID: 33331120]

MeSH Term

COVID-19
COVID-19 Vaccines
Humans
Immunity, Herd
Mutation
Pandemics
SARS-CoV-2
COVID-19 Drug Treatment

Chemicals

COVID-19 Vaccines